Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications
Nils C. Gassen, Jakob Hartmann, Anthony S. Zannas, Anja Kretzschmar, Jürgen Zschocke, Giuseppina Maccarrone, Kathrin Hafner, Andreas Zellner, Lorenz Korbinian Kollmannsberger, Klaus V. Wagner, Divya Mehta, Stefan Kloiber, Christoph W. Turck, Susanne Lucae, George Chrousos, Herta Flor, Elisabeth B. Binder, Marcus Ising, Mathias V. Schmidt, Theo Rein (2015). FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications. , 21(2), DOI: https://doi.org/10.1038/mp.2015.38.
Article269 days agoChaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine
Nils C. Gassen, Gabriel R. Fries, Anthony S. Zannas, Jakob Hartmann, Jürgen Zschocke, Kathrin Hafner, Tania Carrillo‐Roa, Jessica Steinbacher, S. Nicole Preißinger, Lianne Hoeijmakers, Matthias Knop, Frank Weber, Stefan Kloiber, Susanne Lucae, George Chrousos, Thomas Carell, Marcus Ising, Elisabeth B. Binder, Mathias V. Schmidt, Joëlle Rüegg, Theo Rein (2015). Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. , 8(404), DOI: https://doi.org/10.1126/scisignal.aac7695.
Article269 days agoThe endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, G. Paul Amminger, Michael Berk, Chiara C. Bortolasci, Michael Maes, Basant K. Puri, André F. Carvalho (2021). The endocannabinoidome in neuropsychiatry: Opportunities and potential risks. , 170, DOI: https://doi.org/10.1016/j.phrs.2021.105729.
Article245 days agoNeurodevelopmental pathways in bipolar disorder
Stefan Kloiber, Joshua D. Rosenblat, M. Ishrat Husain, Abigail Ortiz, Michael Berk, João Quevedo, Eduard Vieta, Michael Maes, Boris Birmaher, Jair C. Soares, André F. Carvalho (2020). Neurodevelopmental pathways in bipolar disorder. , 112, DOI: https://doi.org/10.1016/j.neubiorev.2020.02.005.
Article245 days agoThe endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, G. Paul Amminger, Michael Berk, Chiara C. Bortolasci, Michael Maes, Basant K. Puri, André F. Carvalho (2021). The endocannabinoidome in neuropsychiatry: Opportunities and potential risks. , 170, DOI: https://doi.org/10.1016/j.phrs.2021.105729.
Article245 days ago